Statera Biopharma, Inc.
The momentum for this stock is not very good. Statera Biopharma, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Statera Biopharma, Inc..
Log in to see more information.
News
Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs
Globe Newswire FORT COLLINS, Colo., March 15, 2023 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (OTCPK:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, is pleased to announce it has entered into a ...\n more…